Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Pediatrix Medical (MD) over the last 6 years, with FY2020 value amounting to $84.3 million.

  • Pediatrix Medical's Shares Outstanding (Weighted Average) rose 208.58% to $84.5 million in Q1 2021 from the same period last year, while for Mar 2021 it was $84.5 million, marking a year-over-year increase of 208.58%. This contributed to the annual value of $84.3 million for FY2020, which is 98.33% up from last year.
  • Per Pediatrix Medical's latest filing, its Shares Outstanding (Weighted Average) stood at $84.3 million for FY2020, which was up 98.33% from $83.5 million recorded in FY2019.
  • Over the past 5 years, Pediatrix Medical's Shares Outstanding (Weighted Average) peaked at $92.4 million during FY2017, and registered a low of $83.5 million during FY2019.
  • Moreover, its 4-year median value for Shares Outstanding (Weighted Average) was $87.7 million (2018), whereas its average is $87.8 million.
  • As far as peak fluctuations go, Pediatrix Medical's Shares Outstanding (Weighted Average) plummeted by 835.2% in 2019, and later skyrocketed by 98.33% in 2020.
  • Pediatrix Medical's Shares Outstanding (Weighted Average) (Annual) stood at $92.4 million in 2017, then fell by 1.44% to $91.1 million in 2018, then decreased by 8.35% to $83.5 million in 2019, then increased by 0.98% to $84.3 million in 2020.
  • Its last three reported values are $84.3 million in FY2020, $83.5 million for FY2019, and $91.1 million during FY2018.